The effect of erythropoietin on the severity of retinopathy of prematurity

Eye (Basingstoke)

Volumn 28, Issue 7, 2014, Pages 814-818

  Kandasamy, Y ^a,b   Kumar, P ^a   Hartley, L ^c  

^a TOWNSVILLE HOSPITAL   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ERYTHROPOIETIN; OXYGEN;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; GESTATIONAL AGE; HUMAN; INCIDENCE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NEWBORN; OXYGEN THERAPY; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; RETROLENTAL FIBROPLASIA; RETROSPECTIVE STUDY; SCREENING;

EID: 84922063816     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2014.95     Document Type: Article

References (29)

1. Chang HH, Larson J, Blencowe H, Spong CY, Howson CP, Cairns-Smith S et al. Preventing preterm births: Analysis of trends and potential reductions with interventions in 39 countries with very high human development index. Lancet 2013; 381(9862): 223-234.
2. Gilbert C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008; 84(2): 77-82.
3. Smith LE, Hard AL, Hellstrom A. The biology of retinopathy of prematurity: How knowledge of pathogenesis guides treatment. Clin Perinatol 2013; 40(2): 201-214.
4. Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2012; 10: CD004865.
5. Slusarski JD, McPherson RJ, Wallace GN, Juul SE. High-dose erythropoietin does not exacerbate retinopathy of prematurity in rats. Pediatr Res 2009; 66(6): 625-630.
6. Mowat FM, Gonzalez F, Luhmann UF, Lange CA, Duran Y, Smith AJ et al. Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy. Am J Pathol 2012; 180(4): 1726-1739.
7. Schneider JK, Gardner DK, Cordero L. Use of recombinant human erythropoietin and risk of severe retinopathy in extremely low-birth-weight infants. Pharmacotherapy 2008; 28(11): 1335-1340.
8. Egrie JC, Browne JK. Development and characterization of novel erythropoiesis stimulating protein (NESP). Br J Cancer 2001; 84(S1): 3-10. (Pubitemid 32453429)
9. Ohls RK, Christensen RD, Kamath-Rayne BD, Rosenberg A, Wiedmeier SE, Roohi M et al. A randomized, masked, placebo-controlled study of Darbepoetin Alfa in preterm infants. Pediatrics 2013; 132(1): E119-e127.
10. ICCROP. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123(7): 991-999.
11. Kandasamy Y, Smith R, Wright IM, Hartley L. Pain relief for premature infants during ophthalmology assessment. J Aapos 2011; 15(3): 276-280.
12. Kandasamy Y, Smith R, Wright I, Hartley L. Use of digital retinal imaging in screening for retinopathy of prematurity. J Paediatr Child Health 2013; 49(1): E1-E5.
13. Hellstrom A, Smith LE, Dammann O. Retinopathy of prematurity. Lancet 2013; 382(9902): 1445-1457.
14. Romagnoli C, Tesfagabir MG, Giannantonio C, Papacci P. Erythropoietin and retinopathy of prematurity. Early Hum Dev 2011; 87(Suppl 1): S39-S42.
15. Lubetzky R, Stolovitch C, Dollberg S, Mimouni FB, Salomon M, Mandel D. Nucleated red blood cells in preterm infants with retinopathy of prematurity. Pediatrics 2005; 116(5): E619-e622. (Pubitemid 46056392)
16. Zhu C, Kang W, Xu F, Cheng X, Zhang Z, Jia L et al. Erythropoietin improved neurologic outcomes in newborns with hypoxic-ischemic encephalopathy. Pediatrics 2009; 124(2): E218-e226.
17. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH. Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 2002; 64(2): 326-333.
18. Juul SE, Yachnis AT, Christensen RD. Tissue distribution of erythropoietin and erythropoietin receptor in the developing human fetus. Early Hum Dev 1998; 52(3): 235-249. (Pubitemid 28548695)
19. Wang GL, Semenza GL. General involvement of hypoxiainducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci USA 1993; 90(9): 4304-4308. (Pubitemid 23134215)
20. Watanabe D, Suzuma K, Matsui S, Kurimoto M, Kiryu J, Kita M et al. Erythropoietin as a retinal angiogenic factor in proliferative diabetic retinopathy. N Engl J Med 2005; 353(8): 782-792. (Pubitemid 41215487)
21. Patel S, Rowe MJ, Winters SA, Ohls RK. Elevated erythropoietin mRNA and protein concentrations in the developing human eye. Pediatr Res 2008; 63(4): 394-397. (Pubitemid 351450585)
22. Chen J, Connor KM, Aderman CM, Smith LE. Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 2008; 118(2): 526-533. (Pubitemid 351206543)
23. Suk KK, Dunbar JA, Liu A, Daher NS, Leng CK, Leng JK et al. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: A multiple regression model. J Aapos 2008; 12(3): 233-238. (Pubitemid 351853461)
24. Spasojevic SD, Stojanovic VD, Barisic NA, Doronjski AR, Zikic DR, Babovic SM. Neuroprotective effects of hypothermia and erythropoietin after perinatal asphyxia in newborn rats. J Matern Fetal Neonatal Med 2013; 26(15): 1506-1509.
25. Fan X, Heijnen CJ, van der KM, Groenendaal F, van Bel F. Beneficial effect of erythropoietin on sensorimotor function and white matter after hypoxia-ischemia in neonatal mice. Pediatr Res 2011; 69(1): 56-61.
26. Elmahdy H, El-Mashad AR, El-Bahrawy H, El-Gohary T, El-Barbary A, Aly H. Human recombinant erythropoietin in asphyxia neonatorum: Pilot trial. Pediatrics 2010; 125(5): E1135-e1142.
27. Stojanovic V, Vuckovic N, Spasojevic S, Barisic N, Doronjski A, Zikic D. The influence of EPO and hypothermia on the kidneys of rats after perinatal asphyxia. Pediatr Nephrol 2012; 27(1): 139-144.
28. Wang T, Hu Y, Leach MK, Zhang L, Yang W, Jiang L et al. Erythropoietin-loaded oligochitosan nanoparticles for treatment of periventricular leukomalacia. Int J Pharm 2012; 422(1-2): 462-471.
29. Tempera A, Stival E, Piastra M, De Luca D, Ottaviano C, Tramontozzi P et al. Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants. J Matern Fetal Neonatal Med 2011; 24(8): 1060-1064.